Trials / Conditions / Recurrent Intravascular Large B-Cell Lymphoma
Recurrent Intravascular Large B-Cell Lymphoma
3 registered clinical trials studyying Recurrent Intravascular Large B-Cell Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphom NCT06834373 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lym NCT05507541 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin NCT05202782 | Northwestern University | Phase 2 |